Skip to main content

Table 1 Study Flow Diagram

From: Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial

  1. aMini-International Neuropsychiatric Interview
  2. bThe short version of the official WHO quality of life questionnaire
  3. cthe 3-level EuroQol scale to describe and value health
  4. dClinical Global Impression
  5. eiMTA Productivity Cost-effectiveness questionnaire
  6. fiMTA Medical Consumption questionnaire
  7. gBrief Psychiatric Rating Scale
  8. hCommunity Assessment of Psychic Experiences
  9. iSimple Physical Activity questionnaire
  10. j6 Minutes Timed Walking Test
  11. kIncluding height (first visit only), weight, BMI, systolic and diastolic blood pressure, pulse, waist circumference
  12. lIncluding CRP, GFR, LDL, HDL, triglycerides, insulin, glucose, HbA1c
  13. mxa – xb Metformin dose 1000 mg daily, xb – xc Metformin dose up to 2000 mg daily